文献速递创伤与烧伤心脑血管急症复苏、休克与脓毒症

院前血浆复苏与创伤性脑损伤后神经功能改善相关

Prehospital plasma resuscitation associated with improved neurologic outcomes after traumatic brain injury.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论回顾性单中心资料显示,重型创伤性脑损伤患者院前仅用解冻血浆复苏较仅用浓缩红细胞者出院及随访时神经功能与功能结局更好。

该回顾性研究在单一一级创伤中心纳入2002年1月至2013年12月年龄>15岁、多发伤合并头部损伤、院前接受血液制品复苏的患者,纳入标准为院前仅以浓缩红细胞或解冻血浆作为唯一胶体复苏,排除院内死亡及使用抗凝药者。共76例,53%(n=40)院前接受浓缩红细胞,47%(n=36)接受解冻血浆,两组年龄、性别、损伤严重度、脑损伤严重度、入院实验室值及院前血液制品单位数相似(均p>0.05)。解冻血浆组出院时中位GOSE 7(7-8)优于浓缩红细胞组5.5(3-7),p<0.001;中位DRS 2(1-3.5)优于9(3-13),p<0.001。随访中位6(5-7)个月时,解冻血浆组中位GOSE 8(7-8)优于6(6-7),中位DRS 0(0-1)优于4(2-8),均p<0.001。作者认为这些初步数据支持进一步研究并在危重创伤性脑损伤患者复苏中使用血浆。

要点

  • 院前仅用解冻血浆复苏的创伤性脑损伤患者出院时中位GOSE 7(7-8),优于仅用浓缩红细胞者的5.5(3-7),p<0.001。
  • 出院时中位DRS在解冻血浆组为2(1-3.5),优于浓缩红细胞组的9(3-13),p<0.001。
  • 随访中位6(5-7)个月时,解冻血浆组中位GOSE 8(7-8)优于浓缩红细胞组6(6-7),p<0.001。
  • 随访中位DRS在解冻血浆组为0(0-1),优于浓缩红细胞组的4(2-8),p<0.001。
  • 两组年龄、性别、损伤严重度、脑损伤严重度、入院实验室值及院前血液制品单位数相似(均p>0.05)。

适用人群与场景

  • 年龄>15岁的多发伤合并头部损伤患者,在单一一级创伤中心于2002年1月至2013年12月期间接受院前血液制品复苏。
  • 纳入标准为院前仅以浓缩红细胞或解冻血浆作为唯一胶体复苏;排除院内死亡患者及使用抗凝药患者。

研究设计与关键结果

  • 研究类型为回顾性研究,单中心,共纳入76例符合标准患者,53%(n=40)院前接受浓缩红细胞,47%(n=36)接受解冻血浆。
  • 出院时神经功能:解冻血浆组中位GOSE 7(7-8)vs 浓缩红细胞组5.5(3-7),p<0.001。
  • 出院时功能:解冻血浆组中位DRS 2(1-3.5)vs 浓缩红细胞组9(3-13),p<0.001。
  • 随访中位6(5-7)个月时神经功能:解冻血浆组中位GOSE 8(7-8)vs 浓缩红细胞组6(6-7),p<0.001。
  • 随访中位6(5-7)个月时功能:解冻血浆组中位DRS 0(0-1)vs 浓缩红细胞组4(2-8),p<0.001。
  • 两组年龄、性别、损伤严重度或脑损伤严重度、入院实验室值及院前血液制品单位数相似(均p>0.05)。

证据类型、等级与局限

  • 证据类型为回顾性研究,证据等级为治疗性,level V。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在危重创伤性脑损伤患者中,早期以解冻血浆复苏与出院时及随访期间神经功能和功能结局改善相关,这些初步数据支持进一步研究并在危重创伤性脑损伤患者复苏中使用血浆。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Trauma-related hypotension and coagulopathy worsen secondary brain injury in patients with traumatic brain injuries (TBIs). Early damage control resuscitation with blood products may mitigate hypotension and coagulopathy. Preliminary data suggest resuscitation with plasma in large animals improves neurologic function after TBI; however, data in humans are lacking.

METHODS: We retrospectively identified all patients with multiple injuries age >15 years with head injuries undergoing prehospital resuscitation with blood products at a single Level I trauma center from January 2002 to December 2013. Inclusion criteria were prehospital resuscitation with either packed red blood cells (pRBCs) or thawed plasma as sole colloid resuscitation. Patients who died in hospital and those using anticoagulants were excluded. Primary outcomes were Glasgow Outcomes Score Extended (GOSE) and Disability Rating Score (DRS) at dismissal and during follow-up.

RESULTS: Of 76 patients meeting inclusion criteria, 53% (n = 40) received prehospital pRBCs and 47% (n = 36) received thawed plasma. Age, gender, injury severity or TBI severity, arrival laboratory values, and number of prehospital units were similar (all p > 0.05). Patients who received thawed plasma had an improved neurologic outcome compared to those receiving pRBCs (median GOSE 7 [7-8] vs. 5.5 [3-7], p < 0.001). Additionally, patients who received thawed plasma had improved functionality compared to pRBCs (median DRS 2 [1-3.5] vs. 9 [3-13], p < 0.001). Calculated GOSE and DRS scores during follow-up, median 6 [5-7] months, demonstrated increased function in those resuscitated with thawed plasma compared to pRBCs by both median GOSE (8 [7-8] vs. 6 [6-7], p < 0.001) and DRS (0 [0-1] vs. 4 [2-8], p < 0.001).

CONCLUSION: In critically injured trauma patients with TBI, early resuscitation with thawed plasma is associated with improved neurologic and functional outcomes at discharge and during follow-up compared to pRBCs alone. These preliminary data support the further investigation and use of plasma in the resuscitation of critically injured TBI patients.

LEVEL OF EVIDENCE: Therapeutic, level V.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Hernandez MC, Thiels CA, Aho JM, et al. Prehospital plasma resuscitation associated with improved neurologic outcomes after traumatic brain injury. J Trauma Acute Care Surg. 2017. PMID: 28538641. doi:10.1097/TA.0000000000001581

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。